ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1195 in its research report dated August 14, 2019.
ICICI Direct's research report on Ipca Laboratories
Q1FY20 revenues grew 18.4% YoY to Rs 1011 crore (I-direct estimate: Rs 1013 crore) due to 37% YoY growth in APIs to Rs 298.3 crore (I-direct estimate: Rs 247.4 crore). Domestic revenues grew 12.9% YoY to Rs 452.8 crore (I-direct estimate: Rs 449.1 crore). Export formulations grew 9.3% to Rs 244.8 ...
Read the full text moneycontrol